Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Seizures | 6 | 2018 | 79 | 0.700 |
Why?
|
| Epilepsy | 4 | 2016 | 56 | 0.480 |
Why?
|
| Epilepsy, Temporal Lobe | 4 | 2022 | 18 | 0.420 |
Why?
|
| Electroencephalography | 7 | 2018 | 135 | 0.390 |
Why?
|
| Temporal Lobe | 3 | 2016 | 24 | 0.270 |
Why?
|
| Psychophysiologic Disorders | 2 | 2016 | 8 | 0.250 |
Why?
|
| Epilepsies, Partial | 2 | 2018 | 3 | 0.230 |
Why?
|
| Seizures, Febrile | 1 | 2022 | 1 | 0.200 |
Why?
|
| Encephalocele | 2 | 2022 | 4 | 0.170 |
Why?
|
| Brain | 2 | 2018 | 1452 | 0.150 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 2018 | 1 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 577 | 0.150 |
Why?
|
| Anticonvulsants | 2 | 2016 | 39 | 0.140 |
Why?
|
| Cranial Fossa, Middle | 1 | 2015 | 1 | 0.120 |
Why?
|
| Neurology | 1 | 2015 | 13 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2022 | 1586 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 163 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 146 | 0.110 |
Why?
|
| Leishmania | 2 | 2007 | 19 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2015 | 98 | 0.110 |
Why?
|
| Positron-Emission Tomography | 2 | 2016 | 93 | 0.100 |
Why?
|
| Adult | 11 | 2022 | 13458 | 0.100 |
Why?
|
| Hospitalization | 1 | 2015 | 482 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 532 | 0.080 |
Why?
|
| Functional Laterality | 2 | 2009 | 89 | 0.080 |
Why?
|
| Female | 12 | 2022 | 24018 | 0.080 |
Why?
|
| Flatulence | 1 | 2009 | 3 | 0.080 |
Why?
|
| Middle Aged | 9 | 2018 | 11819 | 0.080 |
Why?
|
| Insurance, Major Medical | 1 | 2009 | 5 | 0.080 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2009 | 14 | 0.080 |
Why?
|
| Hypertension | 1 | 2016 | 823 | 0.080 |
Why?
|
| Male | 10 | 2022 | 22779 | 0.080 |
Why?
|
| Aphasia | 1 | 2008 | 3 | 0.070 |
Why?
|
| Amnesia | 1 | 2008 | 8 | 0.070 |
Why?
|
| Status Epilepticus | 1 | 2008 | 15 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2022 | 2485 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 268 | 0.070 |
Why?
|
| Metalloendopeptidases | 1 | 2007 | 15 | 0.070 |
Why?
|
| Movement Disorders | 1 | 2006 | 9 | 0.070 |
Why?
|
| Humans | 13 | 2022 | 42163 | 0.060 |
Why?
|
| Hand | 1 | 2006 | 33 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2008 | 386 | 0.060 |
Why?
|
| Zinc | 1 | 2007 | 130 | 0.060 |
Why?
|
| Protozoan Proteins | 1 | 2007 | 196 | 0.060 |
Why?
|
| Sclerosis | 1 | 2022 | 5 | 0.050 |
Why?
|
| Thionucleotides | 1 | 2001 | 8 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2001 | 15 | 0.050 |
Why?
|
| Ribonuclease H | 1 | 2001 | 11 | 0.050 |
Why?
|
| Polylysine | 1 | 2001 | 9 | 0.050 |
Why?
|
| Young Adult | 3 | 2018 | 4936 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1999 | 61 | 0.040 |
Why?
|
| Spermatozoa | 1 | 1999 | 208 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 228 | 0.030 |
Why?
|
| Tennessee | 1 | 2016 | 88 | 0.030 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2015 | 1 | 0.030 |
Why?
|
| Meningitis | 1 | 2015 | 8 | 0.030 |
Why?
|
| Craniotomy | 1 | 2015 | 5 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 236 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1020 | 0.030 |
Why?
|
| Aged | 3 | 2016 | 7982 | 0.030 |
Why?
|
| Transcription Factors | 1 | 1999 | 722 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 725 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 5950 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2016 | 1574 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1729 | 0.020 |
Why?
|
| Macrophages | 2 | 2007 | 515 | 0.020 |
Why?
|
| Child | 2 | 2009 | 3381 | 0.020 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2009 | 12 | 0.020 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2008 | 1 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2008 | 10 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2008 | 58 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 281 | 0.020 |
Why?
|
| Zinc Sulfate | 1 | 2007 | 2 | 0.020 |
Why?
|
| Automatism | 1 | 2006 | 1 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 2006 | 6 | 0.020 |
Why?
|
| Videotape Recording | 1 | 2006 | 29 | 0.020 |
Why?
|
| Dystonia | 1 | 2006 | 10 | 0.020 |
Why?
|
| Protective Agents | 1 | 2007 | 26 | 0.020 |
Why?
|
| Culture Media | 1 | 2007 | 96 | 0.020 |
Why?
|
| Biological Availability | 1 | 2007 | 115 | 0.020 |
Why?
|
| Infant | 1 | 2009 | 1143 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2009 | 1516 | 0.010 |
Why?
|
| Hippocampus | 1 | 2008 | 591 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 2803 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 1848 | 0.010 |
Why?
|
| Germ-Free Life | 1 | 2001 | 2 | 0.010 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2001 | 14 | 0.010 |
Why?
|
| Leishmaniasis | 1 | 2001 | 7 | 0.010 |
Why?
|
| Phagosomes | 1 | 2001 | 33 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 70 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2001 | 151 | 0.010 |
Why?
|
| Liposomes | 1 | 2001 | 130 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 462 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 385 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 526 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 314 | 0.010 |
Why?
|
| Drug Carriers | 1 | 2001 | 169 | 0.010 |
Why?
|
| Alu Elements | 1 | 1999 | 12 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 686 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 92 | 0.010 |
Why?
|
| BRCA2 Protein | 1 | 1999 | 50 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 295 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2001 | 273 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 506 | 0.010 |
Why?
|
| Hela Cells | 1 | 1999 | 370 | 0.010 |
Why?
|
| United States | 1 | 2009 | 5072 | 0.010 |
Why?
|
| Breast | 1 | 1999 | 139 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 997 | 0.010 |
Why?
|
| Animals | 2 | 2007 | 16695 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1999 | 534 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 1188 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 1559 | 0.010 |
Why?
|
| DNA | 1 | 1999 | 594 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 557 | 0.010 |
Why?
|
| Cell Line | 1 | 1999 | 1416 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 1554 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1999 | 933 | 0.010 |
Why?
|
| Mice | 1 | 2001 | 6490 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 1679 | 0.000 |
Why?
|